Article Type
Changed
Thu, 12/15/2022 - 15:11
Display Headline
Understanding the Risks of Neuropathic Pain After Chemotherapy

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 28(2)
Publications
Topics
Page Number
34
Legacy Keywords
neuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancerneuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancer
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 28(2)
Issue
Federal Practitioner - 28(2)
Page Number
34
Page Number
34
Publications
Publications
Topics
Article Type
Display Headline
Understanding the Risks of Neuropathic Pain After Chemotherapy
Display Headline
Understanding the Risks of Neuropathic Pain After Chemotherapy
Legacy Keywords
neuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancerneuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancer
Legacy Keywords
neuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancerneuropathic pain, NP, cancers, chemotherapy, pain management, chemotherapy-induced peripheral neuropathy, CIPN, paclitaxel, breast cancer
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media